Company intelligence / Profile preview

Evinova

Cambridge, England, United Kingdomastrazeneca.com ↗

Ownership: Private
Development stage: Commercial

Overview

Evinova offers evidence-led, science-based digital health solutions to optimize clinical trial design and delivery. Its technologies are already used in AstraZeneca-sponsored trials across more than 40 countries. The company focuses on accelerating drug development timelines, improving patient experience in trials, enabling remote monitoring, supporting decentralized trials, and reducing costs for sponsors.

Therapeutic areas: Other
Modalities: DeviceDigital therapeuticsRemote patient monitoring (digital)AI-enabled digital solutions
Industry: Digital Health Medical Devices

Partnerships

Parexel (CRO)Fortrea (CRO)AccentureAmazon Web Services

Beyond the preview

Go deeper on Evinova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evinova.

Explore the full profile